EDITOR: Kerrin M. Green, MA, Assistant Managing Editor, JNCCN—Journal of the National Comprehensive Cancer Network, has disclosed that she has no relevant financial relationships.
CE AUTHORS: Deborah J. Moonan, RN, BSN, Manager, CE Supporter Outreach, has disclosed the following relationships with commercial interests: AstraZeneca: Stockholder/Former Employee. Kristina M. Gregory, RN, MSN, OCN, Vice President, Clinical Information Operations, has disclosed that she has no relevant financial relationships. James Prazak, RPh, Assistant Director, Continuing Education and Grants, has disclosed the following relationships with commercial interests: Bristol-Myers Squibb Company: Pension; Pfizer, Inc: Stockholder; United Healthcare Group: Stockholder; Johnson & Johnson: Stockholder. Nicole R. McMillian, MS, Guidelines Coordinator, has disclosed no relevant financial relationships. Miranda Hughes, PhD, Oncology Scientist/Senior Medical Writer, has disclosed no relevant financial relationships.
LocherJLBonnerJACarrollWR. Prophylactic percutaneous endoscopic gastrostomy tube placement in treatment of head and neck cancer: a comprehensive review and call for evidence-based medicine. JPEN J Parenter Enteral Nutr2011;35:365–374.
MachtayMMoughanJFarachA. Hypopharyngeal dose is associated with severe late toxicity in locally advanced head-and-neck cancer: an RTOG analysis. Int J Radiat Oncol Biol Phys2012;84:983–989.
NugentBParkerMJMcIntyreIA. Nasogastric tube feeding and percutaneous endoscopic gastrostomy tube feeding in patients with head and neck cancer. J Hum Nutr Diet2010;23:277–284.
LangiusJAvan DijkAMDoornaertP. More than 10% weight loss in head and neck cancer patients during radiotherapy is independently associated with deterioration in quality of life. Nutr Cancer2013;65:76–83.
EhrssonYTLangius-EklofALaurellG. Nutritional surveillance and weight loss in head and neck cancer patients. Support Care Cancer2012;20:757–765.
LeeJHMachtayMUngerLD. Prophylactic gastrostomy tubes in patients undergoing intensive irradiation for cancer of the head and neck. Arch Otolaryngol Head Neck Surg1998;124:871–875.
LangendijkJADoornaertPVerdonck-de LeeuwIM. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J Clin Oncol2008;26:3770–3776.
OttossonSZackrissonBKjellenE. Weight loss in patients with head and neck cancer during and after conventional and accelerated radiotherapy. Acta Oncol2013;52:711–718.
AugustDAHuhmannMB. A.S.P.E.N. clinical guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. JPEN J Parenter Enteral Nutr2009;33:472–500.
GargSYooJWinquistE. Nutritional support for head and neck cancer patients receiving radiotherapy: a systematic review. Support Care Cancer2010;18:667–677.
RabeneckLMcCulloughLBWrayNP. Ethically justified, clinically comprehensive guidelines for percutaneous endoscopic gastrostomy tube placement. Lancet1997;349:496–498.
XiS. Effectiveness of voice rehabilitation on vocalisation in postlaryngectomy patients: a systematic review. Int J Evid Based Healthc2010;8:256–258.
NuttingCMMordenJPHarringtonKJ. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol2011;12:127–136.
WeinsteinGSO’MalleyBWJrMagnusonJS. Transoral robotic surgery: a multicenter study to assess feasibility, safety, and surgical margins. Laryngoscope2012;122:1701–1707.
DowthwaiteSAFranklinJHPalmaDA. The role of transoral robotic surgery in the management of oropharyngeal cancer: a review of the literature. ISRN Oncol2012;2012:945162.
AdelsteinDJRidgeJABrizelDM. Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia. Head Neck2012;34:1681–1703.
GomesCAJrLustosaSAMatosD. Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances. Cochrane Database Syst Rev2012;3:CD008096.
WiggenraadRGFliermanLGoossensA. Prophylactic gastrostomy placement and early tube feeding may limit loss of weight during chemoradiotherapy for advanced head and neck cancer, a preliminary study. Clin Otolaryngol2007;32:384–390.
RaykherACorreaLRussoL. The role of pretreatment percutaneous endoscopic gastrostomy in facilitating therapy of head and neck cancer and optimizing the body mass index of the obese patient. JPEN J Parenter Enteral Nutr2009;33:404–410.
ChenAMLiBQLauDH. Evaluating the role of prophylactic gastrostomy tube placement prior to definitive chemoradiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys2010;78:1026–1032.
MekhailTMAdelsteinDJRybickiLA. Enteral nutrition during the treatment of head and neck carcinoma: is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube?Cancer2001;91:1785–1790.
LawsonJDGaultneyJSabaN. Percutaneous feeding tubes in patients with head and neck cancer: rethinking prophylactic placement for patients undergoing chemoradiation. Am J Otolaryngol2009;30:244–249.
ChengSSTerrellJEBradfordCR. Variables associated with feeding tube placement in head and neck cancer. Arch Otolaryngol Head Neck Surg2006;132:655–661.
TerrellJERonisDLFowlerKE. Clinical predictors of quality of life in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg2004;130:401–408.
McLaughlinBTGokhaleASShuaiY. Management of patients treated with chemoradiotherapy for head and neck cancer without prophylactic feeding tubes: the University of Pittsburgh experience. Laryngoscope2010;120:71–75.
GardenASKiesMSMorrisonWH. Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21st century. Radiat Oncol2013;8:21.
NugentBLewisSO’SullivanJM. Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy. Cochrane Database Syst Rev2010:CD007904.